Hormonal
Dynamic aerobic endurance training significantly reduces resting and daytime ambulatory blood pressure in hypertensive patients, with effects mediated by reduced systemic vascular resistance and sympathetic tone.
Engage in moderate-intensity aerobic exercise (like brisk walking, jogging, or cycling) on most days of the week. You do not need to train for hours; sessions as short as 15-40 minutes are effective. Consistency matters more than extreme intensity. This is a primary, non-pharmacological treatment for lowering blood pressure.
After weighting for the number of trained participants, training induced significant net reductions in resting and daytime ambulatory blood pressure of, respectively, 3.0/2.4 mmHg (P < 0.001) and 3.3/3.5 mmHg (P < 0.01)... The reduction in resting blood pressure was more pronounced in the 30 hypertensive study groups ( – 6.9/ – 4.9) than in the others ( – 1.9/ – 1.6; P < 0.001 for all).
Why this rating
Based on a meta-analysis of 72 randomized controlled trials involving 3936 participants.
Source
Effect of exercise on blood pressure control in hypertensive patients
Robert Fagard et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2007
DOI 10.1097/hjr.0b013e3280128bbb
More from this paper
- Endurance training reduces blood pressure primarily by lowering systemic vascular resistance through decreased sympathetic nervous system activity and renin-angiotensin system activity.Good
- Resistance training reduces blood pressure in non-hypertensive populations, but evidence for hypertensive patients is currently insufficient due to a lack of dedicated trials.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →